Advertisement

February 18, 2026

InVera Medical’s Venous Infusion Device Gains CE Mark

February 18, 2026—Irish medtech company InVera Medical announced the CE Mark approval of its InVera Infusion Device. The device may now be marketed and used in the European Union.

The InVera platform uses a catheter inserted into the vein under ultrasound guidance and is designed to enhance infusion of physician-specified agents more effectively, the company said. The procedure requires only a local anesthetic.

“Securing CE Mark is a major milestone for InVera Medical and a significant step towards making this technology available to patients across Europe,” said InVera CEO and Co-Founder Stephen Cox in the company's announcement. “Our focus has been on developing a less invasive, effective, nonthermal approach that fits easily into existing clinical practice while improving the treatment experience for both physicians and patients.

Advertisement


February 19, 2026

Bayer’s Asundexian Reduced Recurrent Ischemic Stroke in OCEANIC-STROKE

February 18, 2026

Sentante Enters FDA TAP Program for Remote Stroke System


)